Matches in Nanopublications for { ?s ?p "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP409192.RAksjfgrr3XmNdJd83iYISI0RrmfaiocbawEiCQsJovH0130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409192.RAksjfgrr3XmNdJd83iYISI0RrmfaiocbawEiCQsJovH0130_provenance.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.
- NP553564.RALOBvtuR2EHhvQD4uGMWQ4DoyGxqqARqcf5ZK9jjbM4U130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553564.RALOBvtuR2EHhvQD4uGMWQ4DoyGxqqARqcf5ZK9jjbM4U130_provenance.
- NP1010926.RAWZ3xnu1C4A_TrlL2SJRp6BNHNcVq3l3DzusgW_fW2DM130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010926.RAWZ3xnu1C4A_TrlL2SJRp6BNHNcVq3l3DzusgW_fW2DM130_provenance.
- assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1116097.RAZQbxhP8XxxkTBU0rF54JHEs4igCrIA6n1XAQ_IrrrYU130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116097.RAZQbxhP8XxxkTBU0rF54JHEs4igCrIA6n1XAQ_IrrrYU130_provenance.
- assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1116094.RACM1YsXHZfG3a8XR_X9lJpDUnSN6PnUX2iRQBLHtXWRc130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116094.RACM1YsXHZfG3a8XR_X9lJpDUnSN6PnUX2iRQBLHtXWRc130_provenance.
- NP691654.RA3_YvPOWCLUTVhdfE7IJOtVMazCPo2bWevJd1bV5KWK4130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691654.RA3_YvPOWCLUTVhdfE7IJOtVMazCPo2bWevJd1bV5KWK4130_provenance.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.
- NP1005555.RA3dIUyRDZNuaepGP512atpekUSiQUnYHhvtEysznR4E4130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005555.RA3dIUyRDZNuaepGP512atpekUSiQUnYHhvtEysznR4E4130_provenance.